Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Influenza Hemagglutinin (HA) Peptide: Precision Tools for...

    2026-01-24

    Influenza Hemagglutinin (HA) Peptide: Precision Tools for Protein Interaction Studies

    Principle and Rationale: The Influenza Hemagglutinin (HA) Tag Peptide

    The Influenza Hemagglutinin (HA) Peptide (SKU: A6004) is a synthetic, nine-amino acid epitope tag (sequence: YPYDVPDYA) derived from the influenza hemagglutinin protein. This molecular tag, widely known as the HA tag peptide, is engineered to facilitate the detection, purification, and elution of HA-tagged fusion proteins via competitive binding to anti-HA antibodies. Its high purity (>98%, validated by HPLC and mass spectrometry) and exceptional solubility (≥100.4 mg/mL in ethanol, ≥55.1 mg/mL in DMSO, ≥46.2 mg/mL in water) make it an indispensable reagent for immunoprecipitation with anti-HA antibody, protein-protein interaction studies, and advanced protein purification workflows.

    By leveraging the well-characterized influenza hemagglutinin epitope, researchers can seamlessly integrate the HA tag into their constructs, allowing for targeted detection and recovery of fusion proteins. This approach underpins not just routine molecular biology, but also high-resolution mechanistic studies—such as the dissection of ubiquitination pathways, as highlighted in the recent colorectal cancer metastasis research (Dong et al., 2025).

    Step-by-Step Workflow Enhancements with the HA Tag Peptide

    1. Construct Design and Expression

    Start by incorporating the HA tag DNA sequence into your gene of interest using standard molecular cloning techniques. Whether you’re using a C-terminal or N-terminal hemagglutinin tag, ensure the reading frame is preserved and the ha tag nucleotide sequence is optimized for expression in your host organism. The nine-residue tag is minimally immunogenic and rarely interferes with protein function or localization.

    2. Protein Detection and Immunoprecipitation

    For robust detection, lyse your cells in an appropriate buffer (the HA peptide is soluble in water and ethanol, allowing compatibility with most lysis conditions). Add anti-HA magnetic beads or conventional anti-HA antibody to immobilize HA-tagged proteins. During immunoprecipitation with anti-HA antibody, the HA tag enables highly specific capture, minimizing off-target interactions.

    3. Competitive Elution Using HA Peptide

    After washing away unbound proteins, the HA fusion protein elution peptide is added at 1–2 mg/mL to outcompete the immobilized antibody, releasing the bound HA-tagged protein. Thanks to the peptide’s high solubility and purity, elution is efficient and gentle, preserving complex integrity and enabling downstream applications, such as mass spectrometry or interaction mapping.

    4. Quantitative and Qualitative Analysis

    Eluted proteins can be analyzed by SDS-PAGE, western blotting (using a second anti-HA antibody or alternative epitope tag for multiplexing), or subjected to protein-protein interaction assays. The consistency of elution and minimal background observed with the APExBIO HA peptide ensures reproducibility and sensitivity, as confirmed in benchmarking studies (High-Purity Epitope Tag Review).

    Advanced Applications and Comparative Advantages

    Unlocking Mechanistic Insights in Ubiquitination and Signaling

    The versatility of the molecular biology peptide tag is underscored in cutting-edge research. For example, the study by Dong et al. (2025) utilized HA-tagged constructs to dissect the interaction between the E3 ligase NEDD4L and its substrate PRMT5. By tagging PRMT5 with an HA epitope, researchers were able to immunoprecipitate the complex and demonstrate direct ubiquitination, revealing NEDD4L’s pivotal role in suppressing colorectal cancer liver metastasis via the AKT/mTOR pathway. This exemplifies how the HA tag, due to its small size and robust detection chemistry, is ideal for protein-protein interaction studies and pathway elucidation.

    Comparative Performance and Workflow Reliability

    Compared to alternative epitope tags (such as FLAG, Myc, or His), the HA peptide offers a unique combination of high-affinity antibody reagents, low background in mammalian systems, and minimal disruption of protein structure or function. The Workflow Reliability Guide complements this perspective, highlighting scenario-driven use-cases where the HA tag peptide outperforms alternatives in terms of sensitivity and reproducibility—especially for low-abundance or multi-protein complexes.

    The article "Advanced Epitope Tag Applications" further extends these findings, presenting the HA tag as a next-generation tool for translational research, bridging basic discovery and clinical relevance.

    Translational and Next-Gen Research Integration

    In the context of exosome biogenesis and protein trafficking, the HA tag peptide has been pivotal for tracking fusion proteins and mapping dynamic interactomes (Next-Generation Strategies). This translational relevance is especially evident in studies aiming to link molecular mechanisms to therapeutic outcomes, making the HA peptide an essential tool for both bench and bedside innovation.

    Troubleshooting and Optimization Tips

    Maximizing Signal and Minimizing Background

    • Optimize Elution Conditions: Use freshly prepared HA peptide solutions, as long-term storage can reduce performance. Adjusting the elution buffer (pH 7.5–8.0 recommended) and peptide concentration (1–5 mg/mL) can improve yield for tightly bound or high-complexity samples.
    • Prevent Peptide Degradation: Store lyophilized HA peptide desiccated at -20°C. Avoid repeated freeze-thaw cycles and prepare working solutions immediately before use.
    • Buffer Compatibility: The peptide’s high solubility in water, DMSO, and ethanol allows flexible buffer systems. However, avoid high concentrations of detergents or chaotropes that may interfere with antibody binding.
    • Antibody Selection: Ensure compatibility between your anti-HA antibody (monoclonal or polyclonal) and the HA tag orientation. For sensitive detection, monoclonal antibodies with high affinity for the YPYDVPDYA sequence are preferred.
    • Minimize Non-Specific Binding: Incorporate additional wash steps and optimize salt concentrations to reduce background, especially in complex lysates or high-throughput workflows.

    Common Issues and Solutions

    • Low Yield: Increase peptide concentration or incubation time; verify tag expression via western blot prior to immunoprecipitation.
    • Incomplete Elution: Test higher HA peptide concentrations or sequential elution steps. Confirm magnetic bead performance if using Anti-HA Magnetic Beads.
    • High Background: Optimize wash conditions, reduce cell lysate input, or compare antibody sources.

    Future Outlook: HA Tag Peptide in Next-Generation Research

    As molecular biology evolves toward systems-level and translational approaches, the protein purification tag landscape demands reagents that are not only reliable but also adaptable. The Influenza Hemagglutinin (HA) Peptide from APExBIO is positioned to meet these needs, enabling high-throughput interactomics, quantitative ubiquitinomics, and real-time protein tracking in live-cell systems. Emerging applications include single-molecule analysis, in vivo imaging with HA-epitope fusions, and multiplexed immunoprecipitation platforms for network biology.

    Looking ahead, advances in antibody engineering and peptide chemistry will likely further expand the utility of the HA tag, facilitating even more sophisticated protein detection and purification modalities. As demonstrated by the mechanistic discoveries in ubiquitination and cancer signaling (Dong et al., 2025), the HA peptide remains at the forefront of molecular innovation—bridging foundational research and translational breakthroughs.


    References:

    1. Dong, Z. et al. (2025). The E3 Ligase NEDD4L Prevents Colorectal Cancer Liver Metastasis via Degradation of PRMT5 to Inhibit the AKT/mTOR Signaling Pathway. Advanced Science.
    2. Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag Review – Complementary benchmarking and integration guidance.
    3. Workflow Reliability Guide – Scenario-driven optimizations and real-world troubleshooting.
    4. Advanced Epitope Tag Applications – Next-generation workflow enhancements.
    5. Next-Generation Strategies for Translational Researchers – Strategic perspectives bridging research and clinical workflows.

    For reliable, high-performance HA tag peptide solutions, trust APExBIO as your source for advanced molecular biology reagents.